BIOMX INC (PHGE) Stock Overview
USA - NYSEARCA:PHGE - US09090D3017 - Common Stock
PHGE Key Statistics, Chart & Performance
The current stock price of PHGE is 0.63 USD. In the past month the price increased by 29.5%. In the past year, price decreased by -33.24%.
PHGE Latest News, Press Relases and Analysis
PHGE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 21.64 | 404.77B | ||
| AMGN | AMGEN INC | 13.47 | 158.20B | ||
| GILD | GILEAD SCIENCES INC | 15.31 | 147.01B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 24.33 | 105.69B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 61.52B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.55 | 60.69B | ||
| ARGX | ARGENX SE - ADR | 87.7 | 49.75B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.2 | 35.25B | ||
| INSM | INSMED INC | N/A | 34.11B | ||
| BNTX | BIONTECH SE-ADR | N/A | 24.67B | ||
| NTRA | NATERA INC | N/A | 23.72B | ||
| BIIB | BIOGEN INC | 9.08 | 21.30B |
Related stock screener links
About PHGE
Company Profile
BiomX, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis and atopic dermatitis. The firm is focused on developing both natural and engineered phage therapies. The company develops therapies to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC) and cancer. The firm discovers and validates bacterial targets and customizes phage compositions against the targets. Its pipeline includes BX001, BX002 and BX003. BX001 is a product candidate that improves the appearance of acne-prone skin. BX002 is a customized phage cocktail that eradicates bacterial targets associated with the onset of IBD. BX003 is a customized phage cocktail developed against specific strains of Klebsiella pneumoniae (Kp).
Company Info
BIOMX INC
22 Einstein St., Floor 4
Ness Ziona MARYLAND 7414002 IL
CEO: Jonathan Solomon
Employees: 55
Phone: 972723942377
BIOMX INC / PHGE FAQ
What is the stock price of BIOMX INC today?
The current stock price of PHGE is 0.63 USD. The price increased by 4.13% in the last trading session.
What is the ticker symbol for BIOMX INC stock?
The exchange symbol of BIOMX INC is PHGE and it is listed on the NYSE Arca exchange.
On which exchange is PHGE stock listed?
PHGE stock is listed on the NYSE Arca exchange.
What is the price forecast or stock price prediction for BIOMX INC stock?
8 analysts have analysed PHGE and the average price target is 15.81 USD. This implies a price increase of 2409.52% is expected in the next year compared to the current price of 0.63. Check the BIOMX INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is BIOMX INC worth?
BIOMX INC (PHGE) has a market capitalization of 16.73M USD. This makes PHGE a Nano Cap stock.
How many employees does BIOMX INC have?
BIOMX INC (PHGE) currently has 55 employees.
What are the support and resistance levels for BIOMX INC (PHGE) stock?
BIOMX INC (PHGE) has a support level at 0.52 and a resistance level at 0.64. Check the full technical report for a detailed analysis of PHGE support and resistance levels.
Should I buy BIOMX INC (PHGE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PHGE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PHGE, evaluating the profitability, health, valuation and growth aspects
- BIOMX INC (PHGE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BIOMX INC (PHGE) Sales and EPS estimates to see what analysts future expectations are.
- BIOMX INC (PHGE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BIOMX INC (PHGE) Insider and Institutional Ownership to learn about the owners and their transactions.
- BIOMX INC (PHGE) Stock Chart to make your own analysis
- BIOMX INC (PHGE) Latest news and press-releases to stay up to date.
Does BIOMX INC (PHGE) stock pay dividends?
PHGE does not pay a dividend.
When does BIOMX INC (PHGE) report earnings?
BIOMX INC (PHGE) will report earnings on 2025-11-12, before the market open.
What is the Price/Earnings (PE) ratio of BIOMX INC (PHGE)?
BIOMX INC (PHGE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.73).
What is the Short Interest ratio of BIOMX INC (PHGE) stock?
The outstanding short interest for BIOMX INC (PHGE) is 1.82% of its float. Check the ownership tab for more information on the PHGE short interest.
PHGE Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to PHGE. When comparing the yearly performance of all stocks, PHGE is one of the better performing stocks in the market, outperforming 75.77% of all stocks.
PHGE Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to PHGE. PHGE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
PHGE Financial Highlights
Over the last trailing twelve months PHGE reported a non-GAAP Earnings per Share(EPS) of -0.73. The EPS decreased by -60.04% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -48.8% | ||
| ROE | -96.91% | ||
| Debt/Equity | 0 |
PHGE Forecast & Estimates
8 analysts have analysed PHGE and the average price target is 15.81 USD. This implies a price increase of 2409.52% is expected in the next year compared to the current price of 0.63.